Press releases

Release
19.06.2018

Cécile Merle appointed to the position of Quality Assurance Director

Download
Release
07.06.2018

VALBIOTIS confirms its deployment in the United-States, to prepare the future commercialization of VALEDIA

Download
Release
15.05.2018

The clinical development of VALEDIA® initiated in the USA

Download
Release
14.05.2018

Evolution in the composition of the board of Directors (in French)

Download
Release
03.04.2018

Annual results 2017

Download
Release
21.03.2018

Dr. Christine Roy-Duval appointed as Director of Development and Medical Affairs

Download
Release
15.03.2018

VALBIOTIS obtains strategic patent for VALEDIA® in the United States

Download
Release
06.03.2018

LpD64 acts on alterations of the microbiota involved in the development of obesity

Download
Release
27.02.2018

Completion of Phase I/II clinical study recruitment for VAL-070, a product to reduce a cardiovascular risk factor

Download